---
title: "Acadia Healthcare (ACHC) Expected to Announce Earnings on Monday"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/239098999.md"
description: "Acadia Healthcare (NASDAQ: ACHC) is set to announce its Q1 2025 earnings on May 12, with expectations of $0.42 per share and $769.90 million in revenue. The stock opened at $23.31, with a market cap of $2.15 billion. Analysts have mixed ratings, with a consensus of \"Moderate Buy\" and an average price target of $50.39. Recent downgrades include Barclays and StockNews.com, while TD Cowen and Royal Bank of Canada have set higher price targets. Acadia Healthcare provides behavioral healthcare services across the U.S. and Puerto Rico."
datetime: "2025-05-07T10:38:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239098999.md)
  - [en](https://longbridge.com/en/news/239098999.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239098999.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/239098999.md) | [繁體中文](https://longbridge.com/zh-HK/news/239098999.md)


# Acadia Healthcare (ACHC) Expected to Announce Earnings on Monday

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) is projected to announce its Q1 2025 earnings results after the market closes on Monday, May 12th. Analysts expect the company to announce earnings of $0.42 per share and revenue of $769.90 million for the quarter.

Get **Acadia Healthcare** alerts:

## Acadia Healthcare Trading Up 2.3 %

-   Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

NASDAQ:ACHC opened at $23.31 on Monday. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 7.64, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a fifty day moving average price of $27.61 and a 200-day moving average price of $37.30. Acadia Healthcare has a one year low of $20.36 and a one year high of $82.41.

## Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Barclays cut shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Royal Bank of Canada decreased their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. TD Cowen dropped their price objective on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Finally, Mizuho decreased their target price on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $50.39.

**Read Our Latest Analysis on Acadia Healthcare**

## About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

## Further Reading

-   Five stocks we like better than Acadia Healthcare
-   What Investors Need to Know About Upcoming IPOs
-   Western Digital: Is the Storage Sector Set for a Rebound?
-   Stock Splits, Do They Really Impact Investors?
-   Wingstop Stock Jumps on Q1 Beat, Expansion Outlook
-   Want to Profit on the Downtrend? Downtrends, Explained.
-   Why Energy Stocks Like Exxon and Hess Are Back in Focus

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### 相关股票

- [Acadia Healthcare (ACHC.US)](https://longbridge.com/zh-CN/quote/ACHC.US.md)
- [Definitive Healthcare (DH.US)](https://longbridge.com/zh-CN/quote/DH.US.md)
- [Unitedhealth (UNH.US)](https://longbridge.com/zh-CN/quote/UNH.US.md)

## 相关资讯与研究

- [Acadia Healthcare Touts Faster Bed Ramp, Reaffirms 2026 Outlook, Eyes Positive Free Cash Flow](https://longbridge.com/zh-CN/news/277532184.md)
- [Acadia Healthcare Q4 revenue beats on volume growth; posts loss due to impairment charge](https://longbridge.com/zh-CN/news/276885459.md)
- [Acadia Healthcare (NASDAQ:ACHC) Updates Q1 2026 Earnings Guidance](https://longbridge.com/zh-CN/news/276931380.md)
- [Acadia Healthcare (NASDAQ:ACHC) Releases FY 2026 Earnings Guidance](https://longbridge.com/zh-CN/news/276892406.md)
- [Public Sector Pension Investment Board Takes $8.92 Million Position in Acadia Healthcare Company, Inc. $ACHC](https://longbridge.com/zh-CN/news/276113432.md)